Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Colorcon
Daiichi Sankyo
McKinsey
Harvard Business School
Queensland Health
Mallinckrodt
AstraZeneca

Generated: October 21, 2018

DrugPatentWatch Database Preview

Cipher Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for CIPHER PHARMS INC, and what generic alternatives to CIPHER PHARMS INC drugs are available?

CIPHER PHARMS INC has two approved drugs.

There is one US patent protecting CIPHER PHARMS INC drugs.

Summary for Cipher Pharms Inc
US Patents:1
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Cipher Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-002 May 7, 2010 RX Yes No 7,858,118 ➤ Sign Up Y ➤ Sign Up
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-004 Aug 1, 2011 RX Yes No ➤ Sign Up ➤ Sign Up
Cipher Pharms Inc LIPOFEN fenofibrate CAPSULE;ORAL 021612-002 Jan 11, 2006 DISCN No No ➤ Sign Up ➤ Sign Up
Cipher Pharms Inc LIPOFEN fenofibrate CAPSULE;ORAL 021612-003 Jan 11, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Cipher Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cipher Pharms Inc LIPOFEN fenofibrate CAPSULE;ORAL 021612-001 Jan 11, 2006 5,545,628 ➤ Sign Up
Cipher Pharms Inc LIPOFEN fenofibrate CAPSULE;ORAL 021612-003 Jan 11, 2006 5,545,628 ➤ Sign Up
Cipher Pharms Inc LIPOFEN fenofibrate CAPSULE;ORAL 021612-002 Jan 11, 2006 5,545,628 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Cipher Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00152 Netherlands ➤ Sign Up PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
C/GB04/012 United Kingdom ➤ Sign Up PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Fuji
Cantor Fitzgerald
Boehringer Ingelheim
Harvard Business School
Accenture
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.